Gastrointestinal & GI Stent Market REPORT OVERVIEW
- Request a Free Sample to learn more about this report
global gastrointestinal & gi stent market size was USD 305.1 million in 2021 and market is projected to touch USD 456.86 Million By 2031, exhibiting a CAGR of 3.8% during the forecast period.
The global COVID-19 pandemic has been unprecedented and staggering, with gastrointestinal & GI stent industry experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
A gastrointestinal & GI stent is a medical device used to treat a variety of disorders affecting the digestive tract. It is sometimes referred to as an esophageal, duodenal, or colonic stent. To keep the GI tract, open and allow the flow of food, fluids, and gases, a tubular construction, commonly composed of metal or plastic, is placed. A GI stent is normally implanted through an endoscopic operation or with the use of a fluoroscope. Using a catheter or endoscope, the stent is squeezed and delivered to the desired area. Once in position, the stent stretches and self-adheres to the GI tract's walls, offering structural support and preserving patency.
Depending on the underlying problem and desired results of the treatment, GI stents can be either temporary or permanent. While the underlying problem is being treated, temporary stents may be utilized to ease obstructions or leaks; they can then be withdrawn when the condition has improved. In situations where surgical intervention is neither possible or preferred, permanent stents may be used. The use of GI stents is a medical treatment that should only be carried out by licensed healthcare professionals, it is crucial to highlight. According to each individual situation, there are different indications, risks, and benefits of using a GI stent; these factors should be reviewed with a gastroenterologist or an interventional radiologist.
COVID-19 Impact: Industry Shutdown Causes Market Distortion
The COVID-19 outbreak caused problems for manufacturers of healthcare materials, including unstable markets, a drop in customer confidence, and difficulties with import and export commerce. The sourcing of raw materials, packaging, and distribution are all parts of the global supply chain. Due to lockdowns, moving commodities, labels, and other items has become difficult. In addition to having an immediate influence on markets, supply chains, supply and demand, and all of these other things, it also had a financial impact on the markets for healthcare. The pandemic altered the dynamics of the industry, compelling organizations to redesign every aspect of their operational frameworks in order to preserve stability amidst the disturbances. Aside from that, the companies' business operations have been affected by the outbreak, which has an effect on the overall healthcare industry. This has partially impacted the gastrointestinal & GI stent industry.
LATEST TRENDS
"Use of Biodegradable Stents to Boost the Market Growth"
A significant development in the gastrointestinal & GI stent market is the growing use of biodegradable stents. When compared to conventional stents, biodegradable stents have a number of advantages because they are made to gradually break down and be absorbed by the body over time. By removing the need for additional procedures to remove the stent, biodegradable stents lower the risk of problems from long-term implantation. The purpose of biodegradable stents is to promote tissue recovery by acting as a temporary scaffolding support for the injured area. To speed up healing and reduce tissue inflammation, they can be coated with bioresorbable compounds that release hormones, growth factors, or medications. Traditional stents, such as metallic stents, remain permanently in the body, potentially causing discomfort and long-term complications. Biodegradable stents, on the other hand, gradually dissolve and are absorbed by the body, eliminating the presence of a foreign object in the long term. Thus, a key trend that is opening up potential for the industry to grow is the growing use of biodegradable stents. These new developments are mostly to blame for the market's overall growth.
Gastrointestinal & GI Stent Market SEGMENTATION
- Request a Free Sample to learn more about this report
- By Types
Based on type, the market is classified into nitinol, stainless steel & plastic.
- By Application
Based on the market is categorized into hospital & ambulatory surgery center.
DRIVING FACTORS
"Minimally Invasive Procedures that Gives the Market Extra Boost"
Minimally invasive procedures have had a significant impact on the gastrointestinal & GI stent market. These procedures have revolutionized the field by providing numerous benefits over traditional open surgeries. Endoscopy plays a crucial role in the placement of GI stents. This procedure involves the insertion of a flexible tube with a camera (endoscope) through the mouth or rectum to access the gastrointestinal tract. Endoscopic placement of stents allows for precise positioning and deployment of the stent, minimizing tissue trauma and reducing the risk of complications. Laparoscopy, also known as keyhole surgery, involves making small incisions and inserting a laparoscope (a long, thin tube with a camera) and other specialized surgical instruments. Laparoscopic-assisted procedures in the GI stent market offer several advantages, including reduced post-operative pain, shorter hospital stays, faster recovery, and improved cosmetic outcomes. Minimally invasive procedures in the GI stent market result in reduced patient trauma compared to open surgeries. Smaller incisions lead to less blood loss, lower risk of infection, and decreased post-operative pain. As a result, the market is expected to continue to grow in the coming years. As a result, the growth, and the minimally invasive procedures will boost the market. It will contribute to the expansion of the healthcare industry and it will improve the overall gastrointestinal & GI stent market growth.
"Technological Advancement to Encourage Market Expansion"
The gastrointestinal (GI) and GI stent industries have benefited significantly from advancements in stent technology. SEMS are metal alloy stents that, when implanted, can expand and take on the shape of the gastrointestinal system. They are frequently employed in the management of GI tract blockages, strictures, and other disorders. SEMS has benefitted such a strong radial force, simple deployment, and the capacity to restore luminal patency to deliver rapid relief. Stents that have a membrane or other covering that encloses the stent mesh are known as covered stents. This coating hinders tissue development and lowers the possibility of stent migration. The technology for stents has recently advanced to include biodegradable stents. These stents are made from materials that gradually degrade and are absorbed by the body over time. Biodegradable stents eliminate the need for long-term stent placement and the associated risks of complications such as stent migration or tissue ingrowth. They are particularly useful in cases where temporary stenting is required, such as in benign strictures or as a bridge to surgery. As a result, these factors are collectively promoting market expansion, increasing company revenues. As a result, above mentioned factors will help the market to boost.
RESTRAINING FACTORS
"High Cost to Impede Market Expansion"
The restraining factor hindering the market is high cost. GI stents and the procedures associated with their placement can be expensive. The cost includes the stent itself, the healthcare professional's fees, hospital charges, and follow-up care. The high cost can limit access to stent placement procedures, particularly in regions with limited healthcare resources or inadequate insurance coverage. These limitations limit the market's overall growth. This may be a significant issue limiting market expansion. If this problem is fixed, the market will start to grow right away.
Gastrointestinal & GI Stent Market REGIONAL INSIGHTS
- Request a Free Sample to learn more about this report
"North America Dominating the Market Across the Globe"
The market for gastrointestinal & GI stent in North America has benefited from the region's expanding industrial development, and various driving factors which has increased the potential sectors as this region is the largest user of the product. The key factor driving the growth of the gastrointestinal & GI stent market share is the growing demand of product in military conflicts, natural disasters & other emergencies one of the major reasons to drive the market. Rapid urbanization developments will further boost the overall market.
KEY INDUSTRY PLAYERS
"Leading Manufacturers to Boost Product Demand"
Study includes information on the market players and where they stand within the sector. Data is being collected and made available through proper research, mergers, technical advancement, growing production facilities, and cooperation. The study on materials offers details on manufacturers, regions, types, applications, sales channels, distributors, traders, dealers, research findings, and more.
List of Market Players Profiled
- BD (U.S.)
- Boston Scientific (U.S.)
- Cook Medical (U.S.)
- Medtronic (Ireland)
REPORT COVERAGE
The study goes into great detail about market segmentation by type and application. The study examines a broad range of participants, including existing and potential market leaders. A considerable market expansion is anticipated as a result of several important factors. In order to provide market insights, the research additionally analyses elements that are probably to boost gastrointestinal & GI stent market share. The report makes forecasts for market expansion during the projected time period. The objective of the regional study is to explain why one region dominates the worldwide market. There are a lot of issues that have all been carefully considered that prevent the industry from growing. The research also contains a market strategic analysis. It includes thorough market information.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 305.1 Million in 2022 |
Market Size Value By |
US$ 456.86 Million by 2031 |
Growth Rate |
CAGR of 3.8% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
1.What value is the gastrointestinal & GI stent market expected to touch by 2031?
Based on our research, the gastrointestinal & GI stent industry is projected to touch USD 456.86 Million By 2031.
-
2.What CAGR is the gastrointestinal & GI stent market expected to exhibit by 2031?
The gastrointestinal & GI stent market is expected to exhibit a CAGR of 3.8% by 2031.
-
3.Which are the driving factors of the market?
Minimally invasive procedures that gives the market extra boost & technological advancement to encourage market expansion.
-
4.What is the restraining factor of the market?
High cost to impede market expansion.